Gingerol - CAS 23513-14-6
Catalog number: B0084-475578
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C17H26O4
Molecular Weight:
294.39
COA:
Inquire
Targets:
COX
Description:
Gingerol is the active constituent of fresh ginger. It is bioactive compound found in ginger (Zingiber officinale) with antioxidant activity, which functions as an anti-inflammatory and antitumor agent. It has been shown to inhibit COX-2 expression.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-475578 25 mg $198 In stock
Bulk Inquiry
Brife Description:
antioxidant activity
Purity:
> 95%
Appearance:
Solid powder
Synonyms:
(S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone;(5S)-5-Hydroxy-1-(4-hydroxy-3-methoxy-phenyl)decan-3-one;3-Decanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-;6-Gingerol; 6-Gingerol; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol
MSDS:
Inquire
Application:
anti-inflammatory, antitumor and antioxidant activity
Quantity:
Milligrams-Grams
InChIKey:
NLDDIKRKFXEWBK-AWEZNQCLSA-N
InChI:
InChI=1S/C17H26O4/c1-3-4-5-6-14(18)12-15(19)9-7-13-8-10-16(20)17(11-13)21-2/h8,10-11,14,18,20H,3-7,9,12H2,1-2H3/t14-/m0/s1
Canonical SMILES:
CCCCCC(CC(=O)CCC1=CC(=C(C=C1)O)OC)O
1.6-Gingerol inhibits Vibrio cholerae-induced proinflammatory cytokines in intestinal epithelial cells via modulation of NF-κB.
Saha P1, Katarkar A1, Das B1, Bhattacharyya A1, Chaudhuri K1. Pharm Biol. 2016 Mar 18:1-10. [Epub ahead of print]
Context The effect of 6-gingerol (6G), the bioactive component of Zingiber officinale Roscoe (Zingiberaceae), in the reduction of Vibrio cholerae (Vibrionaceae)-induced inflammation has not yet been reported. Materials and methods Cell viability assay was performed to determine the working concentration of 6G. Elisa and RT-PCR were performed with Int 407 cells treated with 50 μM 6G and 100 multiplicity of infection (MOI) V. cholerae for 0, 2, 3, 3.5, 6 and 8 h to determine the concentration of IL-8, IL-6, IL-1α and IL-1β in both protein and RNA levels. Furthermore, the effect of 50 μM 6G on upstream MAP-kinases and NF-κB signalling pathways was evaluated at 0, 10, 15, 30, 60 and 90 min. Results The effective dose (ED50) value of 6G was found to be 50 μM as determined by cell viability assay. Pre-treatment with 50 μM 6G reduced V. cholerae infection-triggered levels of IL-8, IL-6, IL-1α and IL-1β by 3.2-fold in the protein level and two-fold in the RNA level at 3.
2.[HPLC combined with PCA technology for analysis of five gingerol compounds in different processing degrees of ginger charcoal].
Yu JY, Chen QF, Lu GY. Zhongguo Zhong Yao Za Zhi. 2015 Nov;40(21):4200-4.
To establish a new method for simultaneously determining the content of five gingerol compounds in different processing degrees of ginger charcoal and PCA principal component analysis was conducted for analysis. Samples were analyzed on Ultimate TM XB-C18 column (4.6 mm x 250 mm, 5 μm) , with acetonitrile (A) -0.1% phosphoric acid solution (B) as mobile phase for gradient elution. Detection wavelength was set at 280 nm. The flow rate was 0.6 mL x min(-1) and the column temperature was 30 degrees C. The five compounds were separated well and showed good linearity (r ≥ 0.999 7) within the concentration ranges tested. The average value for recoveries was between 98.86% - 101.5% (RSD 1.4% - 2.9%). The contents of five compounds showed difference among different processing degrees of ginger charcoal. Zingiberone had the highest content in the standard carbon, and the content of gingerol was decreased as the deepening of processing degree. Different processing degrees of ginger charcoal were classified into three groups with PCA, and provided scientific basis for establishing the quality standards of ginger charcoal.
3.6-gingerol ameliorates gentamicin induced renal cortex oxidative stress and apoptosis in adult male albino rats.
Hegazy AM1, Mosaed MM2, Elshafey SH3, Bayomy NA4. Tissue Cell. 2016 Mar 17. pii: S0040-8166(15)30030-6. doi: 10.1016/j.tice.2016.03.006. [Epub ahead of print]
Ginger or Zingiber officinale which is used in traditional medicine has been found to possess antioxidant effect that can control the generation of free radicals. Free radicals are the causes of renal cell degeneration that leads to renal failure in case of gentamicin induced toxicity. This study was done to evaluate the possible protective effects of 6-gingerol as natural antioxidant on gentamicin-induced renal cortical oxidative stress and apoptosis in adult male albino rats. Forty adult male albino rats were used in this study and were randomly divided into four groups, control group; 6-gingerol treated group; gentamicin treated group and protected group (given simultaneous 6-gingerol and gentamicin). At the end of the study, blood samples were drawn for biochemical study. Kidney sections were processed for histological, and immunohistochemical examination for caspase-3 to detect apoptosis and anti heat shock protein 47 (HSP47) to detect oxidative damage.
4.Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.
Algandaby MM1,2, El-Halawany AM1,3, Abdallah HM1,3, Alahdal AM4, Nagy AA5, Ashour OM6, Abdel-Naim AB7,8. Naunyn Schmiedebergs Arch Pharmacol. 2016 Apr;389(4):419-28. doi: 10.1007/s00210-016-1210-1. Epub 2016 Jan 26.
6-Gingerol (Gin) is known to possess hepatoprotective effects. Liver fibrosis is a major health concern that results in significant morbidity and mortality. There is no FDA-approved medication for liver fibrosis. The present work aimed at exploring the beneficial effects of Gin against liver fibrosis in rats. Experimental fibrosis was induced by challenging animals with CCl4 for 6 weeks. Gin significantly ameliorated the increase in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, albumin, total cholesterol (TC) and triglyceride (TG) concentrations, and liver index. These effects were confirmed by light and electron microscopic examinations. The antifibrotic effects were confirmed by examining Masson trichrome-stained liver sections which indicated reduced collagen deposition in Gin-treated animals. Further, Gin administration hampered alpha-smooth muscle actin (α-SMA) expression and significantly reduced hepatic content of transforming growth factor-beta (TGF-β).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related COX Products


CAS 71125-38-7 Meloxicam

Meloxicam
(CAS: 71125-38-7)

Meloxicam (Mobic) is a nonsteroidal anti-inflammatory agent with analgesic and fever reducer effects.

CAS 141505-32-0 Ibuprofen lysinate

Ibuprofen lysinate
(CAS: 141505-32-0)

Dexibuprofen is a Cyclooxygenase inhibitor originated by Gebro Pharma GmbH. It is a non-steroidal anti-inflammatory drug as the active dextrorotatory enantiomer...

CAS 80382-23-6 Loxoprofen Sodium

Loxoprofen Sodium
(CAS: 80382-23-6)

The parent acid, loxoprofen, is a prodrug that is rapidly converted to its active trans-alcohol metabolite following oral administration.

CAS 162011-90-7 Rofecoxib

Rofecoxib
(CAS: 162011-90-7)

A COX-2 inhibitor( IC50s = 26 nM and > 50 µM in human osteosarcoma cells )

CAS 53716-49-7 Carprofen

Carprofen
(CAS: 53716-49-7)

A COX-2 inhibitor; A non-steroidal anti-inflammatory drug

CAS 101001-34-7 KB3022

KB3022
(CAS: 101001-34-7)

A cyclooxygenase (COX) inhibitor

CAS 169590-42-5 Celecoxib

Celecoxib
(CAS: 169590-42-5)

A highly selective COX-2 inhibitor

CAS 74103-07-4 Ketorolac

Ketorolac
(CAS: 74103-07-4)

A non-selective COX inhibitor of COX-1 and COX-2 with IC50 of 1.23 μM and 3.50 μM, respectively

CAS 189954-96-9 Firocoxib

Firocoxib
(CAS: 189954-96-9)

A selective COX-2 inhibitor

CAS 36322-90-4 Piroxicam

Piroxicam
(CAS: 36322-90-4)

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.

CAS 116686-15-8 FK 3311

FK 3311
(CAS: 116686-15-8)

A selective COX-2 inhibitor

CAS 59804-37-4 Tenoxicam

Tenoxicam
(CAS: 59804-37-4)

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID).Tenoxicam is a good HO. radicals scavenger with an IC50 of 56.7 μM

CAS 2438-72-4 Bufexamac

Bufexamac
(CAS: 2438-72-4)

Bufexamac is a COX inhibitor for IFN-α release with EC50 of 8.9 μM.Bufexamac is a drug used as an anti-inflammatory agent on the skin, as well as rectally. Comm...

PD 127443
(CAS: 121502-05-4)

This active molecular is a Leukotriene B4 antagonist. PD- 127443 is also a 5-lipoxygenase and cyclooxygenase inhibitor and it has been reported to have antiinfl...

CAS 202409-33-4 Etoricoxib

Etoricoxib
(CAS: 202409-33-4)

A selective COX-2 inhibitor

CAS 163133-43-5 4-(NITROOXY)BUTYL (2S)-2-(6-METHOXY-2-NAPHTHYL)PROPANOATE

4-(NITROOXY)BUTYL (2S)-2-(6-METHOXY-2-NA
(CAS: 163133-43-5)

Naproxcinod, a nitro compound, has been found to be a nitric oxide donor as well as a cyclooxygenase inhibitor that was once studied aginast duchenne muscular d...

CAS 22071-15-4 Ketoprofen

Ketoprofen
(CAS: 22071-15-4)

Ketoprofen, (RS)2-(3-benzoylphenyl)-propionic acid (chemical formula C16H14O3) is one of the propionic acid class of nonsteroidal anti-inflammatory drugs (NSAID...

CAS 38194-50-2 Sulindac

Sulindac
(CAS: 38194-50-2)

Sulindac is a non-steroidal COX inhibitor, which potently inhibits prostaglandin synthesis, used in the treatment of acute or chronic inflammatory conditions.

CAS 180200-68-4 JTE522

JTE522
(CAS: 180200-68-4)

JTE522, a selective COX-2 inhibitor, can induce apoptosis and inhibit cell proliferation in human endometrial cancer cell line RL95-2 cells and to explore the m...

CAS 64490-92-2 Tolmetin sodium dihydrate

Tolmetin sodium dihydrate
(CAS: 64490-92-2)

Tolmetin sodium dihydrate is a non-steroidal anti-inflammatory agent for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis.

Chemical Structure

CAS 23513-14-6 Gingerol

Quick Inquiry

Verification code

Featured Items